PF4 and cutaneous mastocytosis: This adds to the data suggesting CXCL4 is involved in CM immunopathogenesis (Srivastava et al., 2008; Srivastava et al., 2010) and may also be used as a diagnostic biomarker of CM alone and in combination of other molecules (Table 1).